Titan Medical to Participate at Upcoming Investment Conferences

TORONTO–(BUSINESS WIRE)–Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq:
TMDI), a medical device company focused on the design, development
and commercialization of a robotic surgical system for application in
single-port minimally invasive surgery (“MIS”), today announced that
Company management will be participating in two upcoming investor
conferences.

• BTIG Annual Healthcare Conference in Snowbird, Utah: February 27 – 28,
  2019. Management will participate in one-on-one meetings with the
  investment community on Wednesday, February 27.
• The 31st Annual ROTH Conference in Laguna Niguel, Calif: March 18 –
  19, 2019. Management will present a corporate overview on Monday,
  March 18 at 11:00 a.m. local time.

The ROTH presentation will be webcast live and available for replay in
the Investors section of Titan Medical’s website at titanmedicalinc.com/investors.

About Titan Medical

Titan Medical Inc. is focused on computer-assisted robotic surgical
technologies for application in minimally invasive surgery. The Company
is developing the SPORT Surgical System, a single-port robotic surgical
system comprised of a surgeon-controlled patient cart that includes a 3D
high-definition vision system and multi-articulating instruments for
performing MIS procedures, and a surgeon workstation that provides an
advanced ergonomic interface to the patient cart and a 3D endoscopic
view inside the patient’s body. Titan intends initially to pursue
focused surgical indications for the SPORT Surgical System, which may
include one or more of gynecologic, urologic, colorectal or general
abdominal procedures.

For more information, please visit the Company’s website at www.titanmedicalinc.com.

Contacts

LHA Investor Relations
Kim Sutton Golodetz
(212) 838-3777
kgolodetz@lhai.com
or
Bruce
Voss
(310) 691-7100
bvoss@lhai.com